Directory for innovators
The AHSN Network can provide you with valuable support in accessing funding opportunities and developing successful partnerships. We lead large regional networks, and our impact rests in our ability to bring people, resources and organisations together, delivering benefits that could not be achieved alone.
Find your nearest AHSN
Search our directoryWhat is my nearest AHSN?
Greater Manchester Research and Innovation Health Accelerator
A new accelerator programme is inviting SMEs to collaborate with Greater Manchester’s research and innovation institutions to support the development of innovative health and care products. The Research and Innovation (R&I) Health Accelerator is open to companies looking to accelerate commercialisation of their product or service into the health and care system. As part of the R&I Health Accelerator, SMEs will be able to access expertise, funding and support to help progress their products and services towards adoption and commercialisation in the health and care system.
£300,000 funding and support programme available for companies with innovative healthcare solutions
Health Innovation Manchester has opened applications for the 2020-2021 Momentum Innovation Fund. The innovation fund has been established to support the introduction and adoption of needs-led, evidence-based innovations into the healthcare system within Greater Manchester and East Cheshire. HInM has also partnered with Danaher Diagnostics on a health accelerator programme to support innovations that provide remote management of patients leaving hospital care and/or patients with long-term conditions at home.
NIHR i4i Product Development Awards Call 21 will open on 20 October 2020.
i4i Product Development Awards (PDA) support innovations at any stage of the translational research and development pathway, including the clinical development of laboratory-validated technologies or interventions.
Innovate UK Smart Grants: Competition closes - Wednesday 25 November 2020 11:00am
Opportunity for UK registered organisations to apply for a share of up to £25 million from Innovate UK to deliver disruptive R&D innovations that can significantly impact the UK economy. Smart is Innovate UK’s ‘Open grant funding’ programme.
The application period for the NHS Innovation Accelerator (NIA) is now open. Closing date 16 October 2020
We are now recruiting for individuals representing high impact, evidence-based innovations that address one or more of this year’s themes: * NHS response to Covid-19 * Mental health * Supporting the NHS workforce
DASA: Biosensing across wide areas. Deadline: 1 June 2020
DASA is looking for solutions to detect and locate deposited hazardous biological agents rapidly in the field. Proposals will need to deliver a higher level of maturity than achieved in Phase 1. We expect the starting Technology Readiness Level (TRL) of the innovation to be TRL 3. By the end of the project, we expect the innovation to be sufficiently developed to achieve approximately TRL 4 – 5. £700k is available to fund Phase 2
Invention for Innovation - Challenge Awards Call 10
The RWI Challenge Award will fund investigations of medtech innovations in healthcare settings. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment. The deadline for this call is on 5 June 2020
Invention for Innovation - Product Development Awards Call 20
The NIHR Invention for Innovation (i4i) programme invites proposals to Call 20 of its researcher-led Product Development Awards (PDA). PDAs fund the development of disruptive early stage medical technologies that address existing or emerging healthcare needs. They support translational projects developing medical devices, active implantable devices and in vitro diagnostic devices.
Bill & Melinda Gates Foundation, Wellcome and Mastercard launch initiative to speed development of and access to therapies for COVID-19
COVID-19 Therapeutics Accelerator will coordinate R&D efforts and remove barriers to drug development and scale-up to address the epidemic. The Bill & Melinda Gates Foundation, Wellcome, and Mastercard has committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments.
COVID-19 Rapid Response Rolling Call
Building on the initial calls of their Initiative, DHSC, through the NIHR, and UKRI are jointly launching a rolling call for proposals for rapid research into COVID-19. As this is a rolling call there is currently no fixed end date to the call, we are open to applications and will aim to review complete proposals within 4 weeks of submission. For UK-led academic, SME and wider industry research that will address a wide range of COVID-19 knowledge gaps/needs, and which will lead to a benefit in UK, potentially international, public health within 12 months
Travel and subsistence funding to support LMIC engagement during the COVID-19 outbreak
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to COVID-19 in low and middle-income countries.
UKRI open call for research and innovation ideas to address COVID-19
UKRI will support excellent proposals of up to 18 months duration which meet at least one of the following: * New research or innovation with a clear impact pathway that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, and response to, the COVID-19 pandemic and its impacts. * Supports the manufacture and/or wide scale adoption of an intervention with significant potential * Gathers critical data and resources quickly for future research use